Last reviewed · How we verify

NCT07345702: BAOCHE-LC

Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct

Not yet recruiting Last updated 20 January 2026
What this trial tests

trial testing Endovascular Therapy in Basilar Artery Occlusion in 518 participants. Not yet recruiting.

Timeline
31 January 2026
Primary endpoint
31 October 2026
31 October 2026

Quick facts

Lead sponsorXuanwu Hospital, Beijing
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment518
Start date31 January 2026
Primary completion31 October 2026
Estimated completion31 October 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xuanwu Hospital, Beijing

Who can join

18 and older, any sex, with Basilar Artery Occlusion or Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter retrospective registry study evaluates the safety and effectiveness of endovascular therapy versus medical therapy for acute large-core basilar artery occlusion. It also investigates clinical, imaging, and laboratory factors associated with functional outcomes and mortality. Patients are grouped according to the treatment received in routine clinical practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Endovascular Therapy

Trials testing the same drug.

Other recruiting trials for Basilar Artery Occlusion

Currently open trials in the same condition.

Other Xuanwu Hospital, Beijing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07345702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing